tiprankstipranks
TipRanksTop Financial ExpertsInsidersAmir Nashat

Amir Nashat Insider Profile

4 Followers
Amir Nashat, Director, Ten Percent Owner at CAMP4 Therapeutics Corporation, holds 1.11M shares in CAMP4 Therapeutics Corporation (Ticker: CAMP), holds 0.00 shares in Morphic Holding (Ticker: MORF), holds 11.03K shares in Fate Therapeutics (Ticker: FATE). Most recently, Amir Nashat Bought ― shares of CAMP4 Therapeutics Corporation on Sep 11, 2025 for an estimated value of $2.00M.
See the Hottest Stocks Based on Insider Trading >
tipranks
Amir Nashat

Amir Nashat
CAMP4 Therapeutics Corporation (CAMP)
Director, Ten Percent Owner

Ranked #101,423 out of 108,921 Corporate Insiders

Profitable Transactions

33%
6 out of 18 Profitable Transactions

Average Return

-24.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$30M
76.37%
16.26%
7.28%
0.09%
0.00% Others
A breakdown of Amir Nashat's holdings
See the Top Stocks by Insiders

Insider Roles

Cartesian Therapeutics
(RNAC)
Director
CAMP4 Therapeutics Corporation
(CAMP)
Director, Ten Percent Owner
Scholar Rock Holding
(SRRK)
Director
Fate Therapeutics
(FATE)
Director
+2 other positions
Roles that Amir Nashat holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Cartesian Therapeutics
(RNAC)
Rating:Informative Buy
Date:Jan 29, 2019 - Jan 29, 2020
Return:+82.70%
The most profitable trade made by Amir Nashat
See the Latest Stocks Traded by Insiders

Amir Nashat's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CAMP
CAMP4 Therapeutics Corporation
Sep 11, 2025
Director, Ten Percent Owner
Informative Buy
2.00M
$4.80M
FATE
Fate Therapeutics
Aug 02, 2019
Director
Uninformative Sell
1.40M
$25.71K
ATYR
aTyr Pharma
―
Director
―
―
SRRK
Scholar Rock Holding
May 13, 2024
Director
Uninformative Buy
―
$2.15M
SYRS
Syros Pharmaceuticals
―
Director
―
―
RNAC
Cartesian Therapeutics
Jan 29, 2019
Director
Informative Buy
1.75M
$22.56M
MORF
Morphic Holding
Aug 20, 2024
―
Uninformative Sell
―
$0.00
MTCR
Metacrine
Sep 22, 2020
―
Uninformative Buy
―
$103.97K
BINDQ
DNIB Unwind, Inc.
―
―
―
$0.00
RCPT
Receptos
May 29, 2014
―
Uninformative Buy
―
$887.71K
List of latest transactions for each holding click on a transaction to see Amir Nashat's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Amir Nashat insider profile FAQ

What is the percentage of profitable transactions made by Amir Nashat?
The percentage of profitable transactions made by Amir Nashat is 33%.
    What is the average return per transaction made by Amir Nashat?
    The average return per transaction made by Amir Nashat is -24.80%.
      What stocks does Amir Nashat hold?
      Amir Nashat holds: CAMP, FATE, ATYR, SRRK, SYRS, RNAC, MORF, MTCR, BINDQ, RCPT stocks.
        What was Amir Nashat’s latest transaction?
        Amir Nashat latest transaction was an Informative Buy of $2.00M.
          What was Amir Nashat's most profitable transaction?
          Amir Nashat’s most profitable transaction was an Informative Buy of RNAC stock on January 29, 2019. The return on the trade was 82.70%.
            What is Amir Nashat's role in CAMP4 Therapeutics Corporation?
            Amir Nashat's role in CAMP4 Therapeutics Corporation is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.